|
AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on ... - Genetic Engineering News (press release) |
 |
|
Genetic Engineering News (press release)Dr. Hutson's presentation, entitled "Phase 2 study of perifosine in patients with metastatic renal cell carcinoma progressing after prior therapy with both ...Updated Single Agent Phase 2 Data of KRX-0401 (Perifosine) in the ... Earthtimes (press release)Keryx Biopharma Announces Updated Clinical Results From Phase 2 ... RTT NewsKeryx Biopharmaceuticals, Inc. to Raise $20 Million in Registered ...
|